Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin added to insulin in hemodialysis patients with type 2 diabetes
2013-004737-33Phase 4Completed
- Sponsor
- Strasbourg University Hospital
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vildagliptin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Strasbourg University Hospital. Primary endpoint: Mean glucose value of continuous glucose monitoring. Started Sep 2015; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2013-004737-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004737-33.